Skip to content

Glibenclamide

Glibenclamide, sold under the brand names Glucovance and Micronase, is a tablet used in the management of Type 2 Diabetes Mellitus. It belongs to a class of medicines that help control blood sugar levels.

Glucovance

Type 2 Diabetes Mellitus

2.5mg + 400mg · 5mg + 500mg

Metformin and glibenclamide tablets for type 2 diabetes. The two drugs lower blood sugar by different routes, so one pill does the work of two separate ones.

From$1.16/ tabletView

Micronase

Type 2 Diabetes Mellitus

2.5mg · 5mg

Glibenclamide tablets for type 2 diabetes. It is a sulfonylurea, a type of medicine that increases insulin output from the pancreas.

From$0.54/ tabletView

Key points

  • Glibenclamide is a sulphonylurea that increases insulin release from the pancreas, lowering blood sugar in Type 2 Diabetes Mellitus.
  • Glucovance combines glibenclamide with metformin in a single tablet, while Micronase contains glibenclamide on its own.
  • Both products are listed as tablets in multiple strengths for adults with Type 2 Diabetes Mellitus.

Glibenclamide is listed for Type 2 Diabetes Mellitus. Glucovance pairs it with metformin in one tablet, which may suit adults who need both medicines together. Micronase is the originator brand for glibenclamide alone, marketed by Pfizer, and Glucovance is listed by Bristol-Myers Squibb. The two tablets differ in their combinations, and the choice depends on the treatment plan prescribed.

Further reading

Related articles